American Financial Advisors’s CorMedix CRMD Stock Holding History

American Financial Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$507K	Sell	64,527 -230	-0.4%	-$1.82K	0.06%	98
2026 Q1	$440K	Buy	64,757 +14,700	+29%	+$109K	0.06%	95
2025 Q4	$582K	Buy	50,057 +5,000	+11%	+$55.3K	0.08%	83
2025 Q3	$524K	Buy	45,057 +11,730	+35%	+$142K	0.07%	93
2025 Q2	$411K	Sell	33,327 -1,200	-3%	-$13.2K	0.06%	104
2025 Q1	$213K	Buy	34,527 +5,000	+17%	+$51.8K	0.03%	139
2024 Q4	$239K	Sell	29,527 -1,000	-3%	-$9.99K	0.03%	132
2024 Q3	$247K	Hold	30,527	–	–	0.03%	128
2024 Q2	$132K	Hold	30,527	–	–	0.02%	142
2024 Q1	$129K	Hold	30,527	–	–	0.02%	148
2023 Q4	$115K	Hold	30,527	–	–	0.02%	142
2023 Q3	$113K	Buy	30,527 +4,000	+15%	+$15.9K	0.02%	132
2023 Q2	$105K	Buy	+26,527	New	+$131K	0.02%	132
2019 Q1	–	Sell	-2,000	Closed	-$13K	–	100
2018 Q4	$13K	Buy	+2,000	New	+$13.4K	﹤0.01%	89

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

American Financial Advisors's CRMD Position: Q2 2026 in Review

American Financial Advisors reduced its CorMedix (CRMD) stake by 0.36% in Q2 2026, selling an estimated $1.82K and leaving 64,527 shares worth $507K. The position accounts for 0.06% of the portfolio, ranked #98.

American Financial Advisors first reported a position in CRMD in Q4 2018 and has held it in 14 quarters since. The position peaked at $582K in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

American Financial Advisors held 64,527 shares of CorMedix worth $507K as of Q2 2026.
American Financial Advisors sold 230 CorMedix shares in Q2 2026, an estimated $1.82K.
CorMedix made up 0.06% of American Financial Advisors's portfolio in Q2 2026, its #98 holding.
American Financial Advisors first reported a position in CorMedix in Q4 2018 and has held it in 14 quarters since.
American Financial Advisors's CorMedix position peaked at $582K in Q4 2025.
193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on American Financial Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.